AGWCA
MEDP icon

Annis Gardner Whiting Capital Advisors’s Medpace MEDP Stock Holding History

Annis Gardner Whiting Capital Advisors’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-16
Closed -$7.68K – 888
2026
Q1 		$7.68K Sell
16
-1
-6% -$512 ﹤0.01% 907
2025
Q4 		$9.55K Buy
+17
New +$9.65K ﹤0.01% 787
2025
Q3 		– Sell
-24
Closed -$7.53K – 1338
2025
Q2 		$7.53K Buy
+24
New +$7.21K ﹤0.01% 785
2024
Q3 		– Sell
-116
Closed -$47.8K – 864
2024
Q2 		$47.8K Buy
116
+19
+20% +$7.52K 0.01% 408
2024
Q1 		$39.2K Buy
+97
New +$34.1K 0.01% 423

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Annis Gardner Whiting Capital Advisors's MEDP Position: Q2 2026 in Review

Annis Gardner Whiting Capital Advisors sold out of Medpace (MEDP) in Q2 2026, closing a stake of 16 shares — an estimated $7.68K sold.

Annis Gardner Whiting Capital Advisors first reported a position in MEDP in Q1 2024 and held it in 5 quarters. The position peaked at $47.8K in Q2 2024. 695 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Annis Gardner Whiting Capital Advisors reported no remaining Medpace position as of Q2 2026 after selling out during the quarter.
  • Annis Gardner Whiting Capital Advisors sold 16 Medpace shares in Q2 2026, an estimated $7.68K.
  • Annis Gardner Whiting Capital Advisors first reported a position in Medpace in Q1 2024 and held it in 5 quarters.
  • Annis Gardner Whiting Capital Advisors's Medpace position peaked at $47.8K in Q2 2024.
  • 695 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Annis Gardner Whiting Capital Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.